Sébastien Rinaldetti studied at the Medical University of Innsbruck (2007-2013) and was a doctoral student at the Tyrolean Cancer Research Institute, graduating in 2013 'Dr.med.univ.'. He also held clinical internships at the Université Libre de Bruxelles (ULB) and at the Center Hospitalier Universitaire Montpellier. He received specialist training in hematology and oncology at the Medical Faculty Mannheim, Heidelberg University (Prof. W.K. Hofmann) with residencies including the intensive care unit and bone marrow transplantation facility. He earned his second doctorate, Dr. med. (Summa Cum Laude) at the Ruprecht-Karls University, Heidelberg. As part of his scientific work at the Center of Excellence for Chronic Myeloid Leukemia (Prof. S. Saussele) and at the Urology Cancer Research Laboratory (Prof. P. Erben) in Mannheim, Sébastien Rinaldetti specialized in the field of personalized and translational medicine. He has also participated in international clinical studies. He completed his postdoc fellowship (2018-2019) in the USA at Colorado University, Anschutz Medical Campus (Prof. D. Theodorescu and Prof. D. LaBarbera), where he deepened his expertise in the field of drug discovery and basic research. He is a member of international scientific and clinical societies (ESMO, EHA, ASCO, DGHO, AACR) and a reviewer of numerous scientific journals (including Blood, Cancers, Nature Publishing Group).